nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—Serum creatinine increased—Tretinoin—peripheral nervous system neoplasm	0.0241	0.0244	CcSEcCtD
Trimetrexate—Serum creatinine increased—Isotretinoin—peripheral nervous system neoplasm	0.0241	0.0244	CcSEcCtD
Trimetrexate—Hepatotoxicity—Tretinoin—peripheral nervous system neoplasm	0.0192	0.0194	CcSEcCtD
Trimetrexate—Hepatotoxicity—Isotretinoin—peripheral nervous system neoplasm	0.0192	0.0194	CcSEcCtD
Trimetrexate—Serum creatinine increased—Alitretinoin—peripheral nervous system neoplasm	0.0183	0.0185	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Topotecan—peripheral nervous system neoplasm	0.0158	0.016	CcSEcCtD
Trimetrexate—Hepatotoxicity—Dactinomycin—peripheral nervous system neoplasm	0.0157	0.0159	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Isotretinoin—peripheral nervous system neoplasm	0.0157	0.0159	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Tretinoin—peripheral nervous system neoplasm	0.0157	0.0159	CcSEcCtD
Trimetrexate—Serum creatinine increased—Cisplatin—peripheral nervous system neoplasm	0.0156	0.0158	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Isotretinoin—peripheral nervous system neoplasm	0.0149	0.015	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Tretinoin—peripheral nervous system neoplasm	0.0149	0.015	CcSEcCtD
Trimetrexate—Hepatotoxicity—Alitretinoin—peripheral nervous system neoplasm	0.0146	0.0147	CcSEcCtD
Trimetrexate—Hypocalcaemia—Dactinomycin—peripheral nervous system neoplasm	0.0133	0.0134	CcSEcCtD
Trimetrexate—Hepatotoxicity—Cisplatin—peripheral nervous system neoplasm	0.0124	0.0126	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Isotretinoin—peripheral nervous system neoplasm	0.0124	0.0125	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Tretinoin—peripheral nervous system neoplasm	0.0124	0.0125	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Alitretinoin—peripheral nervous system neoplasm	0.0119	0.012	CcSEcCtD
Trimetrexate—Hepatotoxicity—Etoposide—peripheral nervous system neoplasm	0.0114	0.0115	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Alitretinoin—peripheral nervous system neoplasm	0.0113	0.0114	CcSEcCtD
Trimetrexate—Hyponatraemia—Melphalan—peripheral nervous system neoplasm	0.0107	0.0108	CcSEcCtD
Trimetrexate—Trimethoprim—ABCB1—peripheral nervous system neoplasm	0.0105	1	CrCbGaD
Trimetrexate—Blood creatinine increased—Tretinoin—peripheral nervous system neoplasm	0.0101	0.0102	CcSEcCtD
Trimetrexate—Blood creatinine increased—Isotretinoin—peripheral nervous system neoplasm	0.0101	0.0102	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Topotecan—peripheral nervous system neoplasm	0.00979	0.00989	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Topotecan—peripheral nervous system neoplasm	0.00959	0.00969	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Alitretinoin—peripheral nervous system neoplasm	0.0094	0.0095	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Etoposide—peripheral nervous system neoplasm	0.00879	0.00888	CcSEcCtD
Trimetrexate—Neutropenia—Topotecan—peripheral nervous system neoplasm	0.00879	0.00888	CcSEcCtD
Trimetrexate—Neutropenia—Tretinoin—peripheral nervous system neoplasm	0.00871	0.00881	CcSEcCtD
Trimetrexate—Neutropenia—Isotretinoin—peripheral nervous system neoplasm	0.00871	0.00881	CcSEcCtD
Trimetrexate—Neutropenia—Melphalan—peripheral nervous system neoplasm	0.0086	0.00869	CcSEcCtD
Trimetrexate—Serum creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00801	0.00809	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Dactinomycin—peripheral nervous system neoplasm	0.00794	0.00802	CcSEcCtD
Trimetrexate—Hyponatraemia—Vincristine—peripheral nervous system neoplasm	0.00791	0.00799	CcSEcCtD
Trimetrexate—Blood creatinine increased—Alitretinoin—peripheral nervous system neoplasm	0.00766	0.00774	CcSEcCtD
Trimetrexate—Serum creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00741	0.00749	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Etoposide—peripheral nervous system neoplasm	0.00733	0.00741	CcSEcCtD
Trimetrexate—Neutropenia—Dactinomycin—peripheral nervous system neoplasm	0.00712	0.0072	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Vincristine—peripheral nervous system neoplasm	0.00709	0.00717	CcSEcCtD
Trimetrexate—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.00699	0.00707	CcSEcCtD
Trimetrexate—Neutropenia—Alitretinoin—peripheral nervous system neoplasm	0.0066	0.00667	CcSEcCtD
Trimetrexate—Blood creatinine increased—Cisplatin—peripheral nervous system neoplasm	0.00652	0.00659	CcSEcCtD
Trimetrexate—Neutropenia—Vincristine—peripheral nervous system neoplasm	0.00636	0.00643	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Cisplatin—peripheral nervous system neoplasm	0.00627	0.00634	CcSEcCtD
Trimetrexate—Anaemia—Topotecan—peripheral nervous system neoplasm	0.00605	0.00611	CcSEcCtD
Trimetrexate—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.006	0.00607	CcSEcCtD
Trimetrexate—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.006	0.00607	CcSEcCtD
Trimetrexate—Anaemia—Melphalan—peripheral nervous system neoplasm	0.00592	0.00599	CcSEcCtD
Trimetrexate—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00563	0.00569	CcSEcCtD
Trimetrexate—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00563	0.00569	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Etoposide—peripheral nervous system neoplasm	0.00563	0.00569	CcSEcCtD
Trimetrexate—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00555	0.00561	CcSEcCtD
Trimetrexate—Hypocalcaemia—Epirubicin—peripheral nervous system neoplasm	0.00538	0.00544	CcSEcCtD
Trimetrexate—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00534	0.0054	CcSEcCtD
Trimetrexate—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00534	0.0054	CcSEcCtD
Trimetrexate—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00523	0.00529	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Epirubicin—peripheral nervous system neoplasm	0.00521	0.00526	CcSEcCtD
Trimetrexate—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00519	0.00524	CcSEcCtD
Trimetrexate—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00519	0.00524	CcSEcCtD
Trimetrexate—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.00516	0.00521	CcSEcCtD
Trimetrexate—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00512	0.00518	CcSEcCtD
Trimetrexate—Hypocalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.00498	0.00503	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Epirubicin—peripheral nervous system neoplasm	0.00493	0.00498	CcSEcCtD
Trimetrexate—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00491	0.00496	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Doxorubicin—peripheral nervous system neoplasm	0.00482	0.00487	CcSEcCtD
Trimetrexate—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00461	0.00465	CcSEcCtD
Trimetrexate—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00457	0.00462	CcSEcCtD
Trimetrexate—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00457	0.00462	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Doxorubicin—peripheral nervous system neoplasm	0.00456	0.00461	CcSEcCtD
Trimetrexate—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00455	0.0046	CcSEcCtD
Trimetrexate—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00451	0.00456	CcSEcCtD
Trimetrexate—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.0044	0.00445	CcSEcCtD
Trimetrexate—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00438	0.00443	CcSEcCtD
Trimetrexate—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00437	0.00441	CcSEcCtD
Trimetrexate—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00437	0.00441	CcSEcCtD
Trimetrexate—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00426	0.00431	CcSEcCtD
Trimetrexate—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00424	0.00429	CcSEcCtD
Trimetrexate—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00422	0.00427	CcSEcCtD
Trimetrexate—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00419	0.00423	CcSEcCtD
Trimetrexate—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00419	0.00423	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.00411	0.00415	CcSEcCtD
Trimetrexate—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00411	0.00415	CcSEcCtD
Trimetrexate—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00405	0.00409	CcSEcCtD
Trimetrexate—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00393	0.00397	CcSEcCtD
Trimetrexate—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00388	0.00392	CcSEcCtD
Trimetrexate—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00383	0.00387	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.0038	0.00384	CcSEcCtD
Trimetrexate—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0038	0.00384	CcSEcCtD
Trimetrexate—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0038	0.00384	CcSEcCtD
Trimetrexate—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00379	0.00383	CcSEcCtD
Trimetrexate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00378	0.00382	CcSEcCtD
Trimetrexate—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00375	0.00379	CcSEcCtD
Trimetrexate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00375	0.00379	CcSEcCtD
Trimetrexate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00375	0.00379	CcSEcCtD
Trimetrexate—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00373	0.00377	CcSEcCtD
Trimetrexate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.0037	0.00374	CcSEcCtD
Trimetrexate—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00363	0.00367	CcSEcCtD
Trimetrexate—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00359	0.00363	CcSEcCtD
Trimetrexate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00357	0.00361	CcSEcCtD
Trimetrexate—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00355	0.00359	CcSEcCtD
Trimetrexate—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00346	0.0035	CcSEcCtD
Trimetrexate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00342	0.00346	CcSEcCtD
Trimetrexate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0034	0.00343	CcSEcCtD
Trimetrexate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00337	0.00341	CcSEcCtD
Trimetrexate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00337	0.00341	CcSEcCtD
Trimetrexate—Rash—Topotecan—peripheral nervous system neoplasm	0.00337	0.0034	CcSEcCtD
Trimetrexate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00337	0.0034	CcSEcCtD
Trimetrexate—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00335	0.00339	CcSEcCtD
Trimetrexate—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00335	0.00339	CcSEcCtD
Trimetrexate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00334	0.00338	CcSEcCtD
Trimetrexate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00334	0.00338	CcSEcCtD
Trimetrexate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00334	0.00337	CcSEcCtD
Trimetrexate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00334	0.00337	CcSEcCtD
Trimetrexate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00334	0.00337	CcSEcCtD
Trimetrexate—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00333	0.00336	CcSEcCtD
Trimetrexate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00333	0.00336	CcSEcCtD
Trimetrexate—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00332	0.00336	CcSEcCtD
Trimetrexate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00331	0.00334	CcSEcCtD
Trimetrexate—Rash—Melphalan—peripheral nervous system neoplasm	0.0033	0.00333	CcSEcCtD
Trimetrexate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0033	0.00333	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00322	0.00325	CcSEcCtD
Trimetrexate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00318	0.00321	CcSEcCtD
Trimetrexate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00317	0.00321	CcSEcCtD
Trimetrexate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00316	0.00319	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00315	0.00319	CcSEcCtD
Trimetrexate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00315	0.00318	CcSEcCtD
Trimetrexate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00315	0.00318	CcSEcCtD
Trimetrexate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00311	0.00314	CcSEcCtD
Trimetrexate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00311	0.00314	CcSEcCtD
Trimetrexate—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.0031	0.00313	CcSEcCtD
Trimetrexate—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00307	0.0031	CcSEcCtD
Trimetrexate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00306	0.00309	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00298	0.00301	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00292	0.00295	CcSEcCtD
Trimetrexate—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00289	0.00292	CcSEcCtD
Trimetrexate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00288	0.00291	CcSEcCtD
Trimetrexate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00284	0.00287	CcSEcCtD
Trimetrexate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00282	0.00285	CcSEcCtD
Trimetrexate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00278	0.00281	CcSEcCtD
Trimetrexate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00275	0.00278	CcSEcCtD
Trimetrexate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00273	0.00276	CcSEcCtD
Trimetrexate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00271	0.00273	CcSEcCtD
Trimetrexate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.0027	0.00273	CcSEcCtD
Trimetrexate—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00267	0.0027	CcSEcCtD
Trimetrexate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00258	0.00261	CcSEcCtD
Trimetrexate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00257	0.0026	CcSEcCtD
Trimetrexate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00255	0.00258	CcSEcCtD
Trimetrexate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00253	0.00256	CcSEcCtD
Trimetrexate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00253	0.00256	CcSEcCtD
Trimetrexate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00248	0.0025	CcSEcCtD
Trimetrexate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00246	0.00249	CcSEcCtD
Trimetrexate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00246	0.00248	CcSEcCtD
Trimetrexate—Rash—Vincristine—peripheral nervous system neoplasm	0.00244	0.00247	CcSEcCtD
Trimetrexate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00244	0.00246	CcSEcCtD
Trimetrexate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00239	0.00241	CcSEcCtD
Trimetrexate—Nausea—Vincristine—peripheral nervous system neoplasm	0.0023	0.00232	CcSEcCtD
Trimetrexate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00225	0.00227	CcSEcCtD
Trimetrexate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00222	0.00224	CcSEcCtD
Trimetrexate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00218	0.0022	CcSEcCtD
Trimetrexate—Rash—Cisplatin—peripheral nervous system neoplasm	0.00216	0.00218	CcSEcCtD
Trimetrexate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00216	0.00218	CcSEcCtD
Trimetrexate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00203	0.00205	CcSEcCtD
Trimetrexate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00199	0.00201	CcSEcCtD
Trimetrexate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00199	0.00201	CcSEcCtD
Trimetrexate—Rash—Etoposide—peripheral nervous system neoplasm	0.00198	0.002	CcSEcCtD
Trimetrexate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00197	0.002	CcSEcCtD
Trimetrexate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00187	0.00189	CcSEcCtD
Trimetrexate—Nausea—Etoposide—peripheral nervous system neoplasm	0.00186	0.00188	CcSEcCtD
Trimetrexate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00184	0.00186	CcSEcCtD
Trimetrexate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00177	0.00179	CcSEcCtD
Trimetrexate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00174	CcSEcCtD
Trimetrexate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00172	0.00174	CcSEcCtD
Trimetrexate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00164	0.00166	CcSEcCtD
Trimetrexate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00159	0.00161	CcSEcCtD
Trimetrexate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00152	0.00153	CcSEcCtD
Trimetrexate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00146	CcSEcCtD
Trimetrexate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.00142	CcSEcCtD
Trimetrexate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00139	0.0014	CcSEcCtD
Trimetrexate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00135	CcSEcCtD
Trimetrexate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.0013	CcSEcCtD
Trimetrexate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00127	CcSEcCtD
Trimetrexate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Trimetrexate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00118	CcSEcCtD
Trimetrexate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Trimetrexate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00113	CcSEcCtD
Trimetrexate—Rash—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00112	CcSEcCtD
Trimetrexate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00112	CcSEcCtD
Trimetrexate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00105	CcSEcCtD
Trimetrexate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Trimetrexate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Trimetrexate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00104	CcSEcCtD
Trimetrexate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000966	0.000976	CcSEcCtD
